Phase
Condition
Neuroblastoma
Cancer (Pediatric)
Retinoblastoma
Treatment
CHEF Intervention Program
Clinical Study ID
Ages < 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Child with any primary cancer diagnosis (non-relapsed, non-secondary malignancy) whohas received cancer-directed therapy that includes chemotherapy and/or radiationtherapy;
Child is within one of the following time windows:
Among those receiving chemotherapy, any time from start of last planned cycleof chemotherapy until 12 months from completion of chemotherapy;
Among those receiving radiation therapy alone or radiation and surgery, anytime from completion of radiation until 12 months post completion;
Child has 1 or more cardiovascular risk factor (defined as any of: body mass index ≥ 85th percentile; systolic or diastolic blood pressure ≥90th percentile; dyslipidemia [triglycerides ≥150 mg/dL, total cholesterol ≥200 mg/dL, LDL cholesterol ≥130 mg/dL,HDL cholesterol ≤40 mg/dL]; impaired glucose metabolism [fasting glucose ≥100 mg/dL,hemoglobin A1c ≥5.7%]; anthracycline exposure ≥100 mg/m2; or any radiation exposureto chest, brain, thoracic spine, or total body);
Child is ≤18 years of age at time of enrollment, or over 18 years of age but undermedical guardianship;
Parent/guardian screened positive for food insecurity.* *Assessed through validated 2-item food insecurity screen.
Exclusion
Exclusion Criteria:
Patient received only surgery, or watchful waiting/surveillance, for cancer-directed therapy;
Foreign national family receiving cancer care as an embassy-pay patient.
Study Design
Study Description
Connect with a study center
Boston Children's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts 02215
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.